Fate of biomedical research protocols and publication bias in France: retrospective cohort study

被引:114
作者
Decullier, E
Lheritier, V
Chapuis, F [1 ]
机构
[1] Hop Hotel Dieu, French Natl Confederat Res Eth Comm, F-69002 Lyon, France
[2] Hosp Civils Lyon, DIM, Clin Res Unit, F-69424 Lyon, France
[3] Hop Hotel Dieu, CCPPRB Lyon B, F-69002 Lyon, France
来源
BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 331卷 / 7507期
关键词
D O I
10.1136/bmj.38488.385995.8F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To describe the fate of protocols approved by the French research ethics committees, a national system created by the French 1988 Huriet-Serusclat Act; to assess publication bias at a national level. Design Retrospective cohort study. Setting Representative sample of 25/48 French research ethics committees in 1994. Protocols 649 research protocols approved by committees, with follow-up information. Main outcome measures Protocols' initial characteristics (design, study size, investigator) abstracted from committees' archives; follow-up information (rates of initiation, completion, and publication) obtained from mailed questionnaire to principal investigators. Results Completed questionnaires were available for 649/976 (69%) protocols. Of these, 581 (90%) studies were initiated, 501/581 (86%) were completed, and 190/501 (38%) were published. Studies with confirmatory results were more likely to be published as scientific papers than were studies with inconclusive results (adjusted odds ratio 4.59, 95% confidence interval 2.21 to 9.54). Moreover, studies with confirmatory results were published more quickly than studies with inconclusive results (hazard ratio 2.48, 1.36 to 4.55). Conclusion At a national level, too many research studies are not completed, and among those completed too many are not published. We suggest capitalising on research ethics committees to register and follow all authorised research on human participants on a systematic and prospective basis.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 13 条
  • [1] Compulsory registration of clinical trials - Will be a requirement before submission to the BMJ from July 2005
    Abbasi, K
    [J]. BRITISH MEDICAL JOURNAL, 2004, 329 (7467): : 637 - 638
  • [2] Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles
    Chan, AW
    Hróbjartsson, A
    Haahr, MT
    Gotzsche, PC
    Altman, DG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20): : 2457 - 2465
  • [3] Clinical trial registration - A statement from the International Committee of Medical Journal editors
    De Angelis, C
    Drazen, JM
    Frizelle, FA
    Haug, C
    Hoey, J
    Horton, R
    Kotzin, S
    Laine, C
    Marusic, A
    Overbeke, AJPM
    Schroeder, TV
    Sox, HC
    Van der Weyden, MB
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (06) : 293 - 294
  • [4] FACTORS INFLUENCING PUBLICATION OF RESEARCH RESULTS - FOLLOW-UP OF APPLICATIONS SUBMITTED TO 2 INSTITUTIONAL REVIEW BOARDS
    DICKERSIN, K
    MIN, YI
    MEINERT, CL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (03): : 374 - 378
  • [5] WHY REGISTER CLINICAL-TRIALS - REVISITED
    DICKERSIN, K
    [J]. CONTROLLED CLINICAL TRIALS, 1992, 13 (02): : 170 - 177
  • [6] REDUCING PUBLICATION BIAS
    EASTERBROOK, P
    [J]. BRITISH MEDICAL JOURNAL, 1987, 295 (6609) : 1347 - 1347
  • [7] PUBLICATION BIAS IN CLINICAL RESEARCH
    EASTERBROOK, PJ
    BERLIN, JA
    GOPALAN, R
    MATTHEWS, DR
    [J]. LANCET, 1991, 337 (8746) : 867 - 872
  • [8] EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71
  • [9] CONSEQUENCES OF PREJUDICE AGAINST NULL HYPOTHESIS
    GREENWALD, AG
    [J]. PSYCHOLOGICAL BULLETIN, 1975, 82 (01) : 1 - 19
  • [10] Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
    Ioannidis, JPA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (04): : 281 - 286